Package Leaflet: Information for the Patient
Biturol 5 mg/5 mg Film-Coated Tablets
finasteride/tadalafil
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Biturol is a combination of two different active substances, finasteride and tadalafil. Finasteride belongs to a group of medicines called 5-alpha reductase inhibitors and tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors.
This medicine is used in men to treat the symptoms caused by an enlarged prostate (benign prostatic hyperplasia), such as difficulty starting to urinate, weak flow, the feeling of not emptying the bladder completely, and frequent need to urinate (even at night). This medicine is used in patients whose symptoms are already controlled with finasteride and tadalafil administered at the same time.
Finasteride helps to reduce the size of an enlarged prostate and relieve symptoms. Tadalafil acts by improving blood flow and relaxing the muscles of the prostate and bladder, which helps to reduce symptoms.
Do not takeBiturol
effects of these medicines. If you are taking any type of nitrate or are not sure, tell your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Biturol.
Tell your doctor about your current and past medical problems and any allergy you suffer from.
Biturol is only intended for the treatment of BPH in males. Women should not use this medicine when they are or may be pregnant, nor should they be exposed to Biturol by handling crushed or broken tablets. If the active ingredient finasteride is absorbed after oral use or through the skin by a woman who is pregnant with a male fetus, the fetus may be born with abnormalities in its sexual organs. If the pregnant woman has come into contact with this active ingredient, she should consult her doctor. The Biturol tablets are film-coated and this will prevent contact with the active ingredients during normal handling, as long as the tablets are not crushed or broken. If you have any doubts, ask your doctor.
If your sexual partner is or may be pregnant, you should avoid exposing her to your semen as it may contain minimal amounts of the drug.
BPH develops over a long period of time. Sometimes the symptoms improve quickly, but you may need to take Biturol for at least six months to see if your symptoms improve. Even if you do not feel any improvement or change in symptoms, therapy with Biturol may reduce the risk of not being able to urinate and therefore the need for surgery. You should see your doctor regularly for periodic check-ups and to assess your progress.
Since benign prostatic hyperplasia and prostate cancer can have the same symptoms, your doctor will perform a prostate cancer screening before starting treatment with Biturol for benign prostatic hyperplasia. Biturol does not treat prostate cancer.
Biturol may decrease the levels of prostate-specific antigen (PSA, a substance in the body that increases when the prostate grows and can cause obstruction). If you have had a PSA test, tell your doctor that you are taking Biturol.
Before taking the tablets, tell your doctor if you have:
It is not known if Biturol is effective in patients who have undergone:
If you experience a sudden decrease or loss of vision or your vision is distorted, blurred while taking finasteride/tadalafil, stop taking Biturol and contact your doctor immediately.
A sudden decrease or loss of hearing has been observed in some patients taking tadalafil. Although it is not known if the event is directly related to tadalafil, if you experience a sudden decrease or loss of hearing, stop taking Biturol and contact your doctor immediately.
Biturol is not intended for use in women.
Mood changes and depression
Mood changes, such as depressed mood, depression, and, less frequently, suicidal thoughts have been reported in patients treated with finasteride. If you experience any of these symptoms, consult your doctor as soon as possible.Children and adolescents
Biturol should not be used in children or adolescents under 18 years of age.
Other medicines and Biturol
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Do not take Biturol if you are already using nitrates.
Some medicines may be affected by Biturol or may affect the proper functioning of Biturol. Tell your doctor or pharmacist if you are using:
Taking Biturol with food, drinks, and alcohol
Information about the effect of alcohol is found in section 3. Grapefruit juice may affect the proper functioning of Biturol and should be taken with caution. Consult your doctor for more information.
Pregnancy, breast-feeding, and fertility
Biturol is for use in men only.
Biturol is not indicated in women.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
In dogs treated with finasteride, a decrease in sperm production by the testicles was observed. A reduction in sperm has been observed in some men. It is unlikely that these effects will produce a lack of fertility.
Driving and using machines
Some men who took tadalafil (one of the components of this medicine) during clinical trials experienced dizziness. Check carefully how you react when taking the tablets before driving or using machines.
Biturol contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Biturol contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially "sodium-free".
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The Biturol tablets are for oral administration only in men. Swallow the tablet whole with a little water. Take one Biturol tablet a day, with or without food.
Consuming alcohol may temporarily lower your blood pressure. If you have taken or are planning to take Biturol, avoid excessive alcohol consumption (blood alcohol level of 0.08% or higher), as it may increase the risk of dizziness when standing up.
Recommended doseis one tablet once a day, approximately at the same time. Do not take Biturol more than once a day.
If you take more Biturol than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
Consult your doctor. You may experience side effects described in section 4.
If you forget to take Biturol
If you realize that you have forgotten to take your dose, wait for the next daily dose.
Do not take a double dose to make up for forgotten doses.
If you stop taking Biturol
If you stop taking this medicine, the initial symptoms may reappear or worsen. Always consult your doctor if you are considering stopping treatment.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. These effects are generally mild to moderate.
If you experience any of the following side effects, stop using the medicine and seek medical help immediately:
You must inform your doctor immediatelyof any change in breast tissue, such as lumps, pain, enlargement, or nipple discharge, as these may be signs of a serious disease, such as breast cancer. In some cases, these side effects disappeared despite the patient continuing to take the medicine. When the symptoms persisted, they generally disappeared after stopping the medicine.
Other side effects that have been reported:
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Myocardial infarction and stroke have also been reported rarely in men taking Biturol. Most of these men had pre-existing heart problems before taking this medicine.
Rarely, cases of decreased or lost vision, partial, transient, or permanent in one or both eyes have been reported.
Some additional rare side effectshave been reported in men taking tadalafil that were not notified during clinical trials. These include:
Frequency not known(cannot be estimated from the available data): depression, decreased sexual desire that continued after stopping the medication, anxiety, irregular heartbeat, elevated liver enzymes, testicular pain, inability to have an erection that continued after stopping the medication; ejaculation problems that continued after stopping the medication, male infertility or poor semen quality. Improvement in semen quality has been reported after stopping the medication.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system: Spanish Medicines and Healthcare Products Agency (AEMPS) (http://www.aemps.gob.es/). By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Biturol
Coating: magnesium stearate, hypromellose, titanium dioxide (E-171), triacetin.
Appearance and packaging
Biturol is presented in the form of film-coated tablets, round, white, biconvex, and without scoring, 8 mm in size.
The tablets are available in blister packs of PVC/PCTFE and an aluminum foil in packs of 30 tablets.
Marketing authorization holder and manufacturer
Laboratorios Alter, S.A.
C/ Mateo Inurria 30
28036 Madrid
Spain
Date of last revision of this leaflet: June 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) (http://www.aemps.gob.es/).
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for BITUROL 5 MG/5 MG FILM-COATED TABLETS – subject to medical assessment and local rules.